Home

Yu-Waye Chu, Chief Medical Officer: Fate Therapeutics FATE Sell · Filed 23/01/11

Trade details

Type
Insider sale
Amount
$41,003
Shares · price
7,825 sh · $5.24 a share
Held after
143,208 sh
Trade date
23/01/10
Filed
23/01/11
Days to filing
1 days

Sold 5.2% of holdings

Share of holding sold
5.2%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 22/12/11~23/02/09

Yu-Waye Chu's recent trades

  • Yu-Waye Chu

    SellCytomX Therapeutics

    $136.6K

    Filed 03/19

  • Yu-Waye Chu

    SellCytomX Therapeutics

    $2,415

    Filed 25/03/20

  • Yu-Waye Chu

    Sell10b5-1 planFate Therapeutics

    $15.2K

    Filed 23/04/19

  • Yu-Waye Chu

    Sell10b5-1 planFate Therapeutics

    $1,402

    Filed 23/04/19